These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34839084)

  • 1. Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy.
    May BM; Kochi AN; Magalhães APA; Scolari F; Zimerman A; Andrades M; Zimerman LI; Rohde LE; Pimentel M
    J Electrocardiol; 2022; 70():19-23. PubMed ID: 34839084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
    Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
    JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.
    Stojkovic S; Kaider A; Koller L; Brekalo M; Wojta J; Diedrich A; Demyanets S; Pezawas T
    J Cell Mol Med; 2018 Apr; 22(4):2422-2429. PubMed ID: 29397580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Differentiation Factor-15 Predicts Mortality and Heart Failure Exacerbation But Not Ventricular Arrhythmias in Patients With Cardiomyopathy.
    Binder MS; Yanek LR; Yang W; Butcher B; Norgard S; Marine JE; Kolandaivelu A; Chrispin J; Fedarko NS; Calkins H; O'Rourke B; Wu KC; Tomaselli GF; Barth AS
    J Am Heart Assoc; 2023 Feb; 12(3):e8023. PubMed ID: 36718879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.
    De Angelis G; Merlo M; Barbati G; Bertolo S; De Luca A; Ramani F; Adamo L; Sinagra G
    J Am Soc Echocardiogr; 2022 Aug; 35(8):801-809.e3. PubMed ID: 35367610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
    Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of serious arrhythmic events in patients with nonischemic heart failure.
    Pimentel M; Zimerman A; Chemello D; Giaretta V; Andrades M; Silvello D; Zimerman L; Rohde LE
    J Interv Card Electrophysiol; 2017 Mar; 48(2):131-139. PubMed ID: 27943114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.
    Rodríguez-Zanella H; Muraru D; Secco E; Boccalini F; Azzolina D; Aruta P; Surkova E; Genovese D; Cavalli G; Sammarco G; Ruozi N; Tenaglia RM; Calvillo-Argüelles O; Palermo C; Iliceto S; Badano LP
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1917-1926. PubMed ID: 30219408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.
    Pour-Ghaz I; Heckle M; Ifedili I; Kayali S; Nance C; Kabra R; Jha SK; Jefferies JL; Levine YC
    Curr Cardiol Rev; 2022; 18(2):e040821195265. PubMed ID: 34348632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy.
    Klem I; Klein M; Khan M; Yang EY; Nabi F; Ivanov A; Bhatti L; Hayes B; Graviss EA; Nguyen DT; Judd RM; Kim RJ; Heitner JF; Shah DJ
    Circulation; 2021 Apr; 143(14):1343-1358. PubMed ID: 33478245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
    Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.